Cargando…

Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and efficacious dose is unknown

Detalles Bibliográficos
Autores principales:	Busse, LW, Brasha, E, Davison, DL, Seneff, MG, Honig, J, Alotaibi, ZK, Chawla, LS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068767/ http://dx.doi.org/10.1186/cc13350

Ejemplares similares

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study
por: Chawla, Lakhmir S, et al.
Publicado: (2014)

The use of angiotensin II in distributive shock
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

Strong ion gap can be accurately estimated with a simple bedside equation
por: Busse, L, et al.
Publicado: (2013)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury
por: Chawla, Lakhmir S, et al.
Publicado: (2013)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

Low-dose norepinephrine in combination with hypotensive resuscitation may prolong the golden window for uncontrolled hemorrhagic shock in rats
por: Zhou, Yuanqun, et al.
Publicado: (2022)

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
por: Ham, Kealy R., et al.
Publicado: (2019)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
por: Wang, Wenjun, et al.
Publicado: (2021)

Glyphosate’s Synergistic Toxicity in Combination with Other Factors as a Cause of Chronic Kidney Disease of Unknown Origin
por: Gunatilake, Sarath, et al.
Publicado: (2019)

Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia
por: Chawla, Lakhmir S, et al.
Publicado: (2008)

Angiotensin converting enzyme defects in shock: implications for future therapy
por: Chawla, Lakhmir S., et al.
Publicado: (2018)

A Case of Dronedarone-Induced Hypotensive Shock
por: Hassib, Mohab, et al.
Publicado: (2020)

A 32-Year-Old Male with Recurrent Hypothermia and Hypotension of Unknown Cause
por: Liu, Ying, et al.
Publicado: (2013)

Permissive hypotensive resuscitation in patients with traumatic hemorrhagic shock
por: Ho, Kai-Hung, et al.
Publicado: (2019)

Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients
por: Andrews, Lauren, et al.
Publicado: (2022)

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
por: Busse, Laurence W., et al.
Publicado: (2017)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

A narrative review of paracetamol‐induced hypotension: Keeping the patient safe
por: Young, Tricia L.
Publicado: (2021)

Reply to Picod et al.: Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
por: Chawla, Lakhmir S.
Publicado: (2021)

Evaluating Molecular Mechanism of Hypotensive Peptides Interactions with Renin and Angiotensin Converting Enzyme
por: He, Rong, et al.
Publicado: (2014)

The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril
por: Watanabe, Machiko, et al.
Publicado: (2015)

Push-Dose Pressors During Peri-intubation Hypotension in the Emergency Department: A Case Series
por: Bakhsh, Abdullah, et al.
Publicado: (2021)

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19
por: Trojaniello, C., et al.
Publicado: (2021)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker
por: Nabbi, Raha, et al.
Publicado: (2013)

Intradialytic hypotension and cardiac remodeling: should we consider the renin-angiotensin-aldosterone system?
por: Wang, Juanli, et al.
Publicado: (2021)

Central and peripheral effects of ghrelin over the hypotension induced by endotoxemic shock
por: Faim, Felipe, et al.
Publicado: (2013)

Testicular failure following severe diabetic ketoacidosis complicated by hypotensive shock
por: Janem, Waleed, et al.
Publicado: (2016)

Hypotension and a positive fluid balance are associated with delirium in patients with shock
por: Nguyen, Duc Nam, et al.
Publicado: (2018)

Utilization of Medical Codes for Hypotension in Shock Patients: A Retrospective Analysis
por: Hunley, Charles, et al.
Publicado: (2021)

Classification of Septic Shock Phenotypes Based on the Presence of Hypotension and Hyperlactatemia in Cats
por: Troia, Roberta, et al.
Publicado: (2021)

Principles of Hypotensive Shock: A Video Introduction to Pathophysiology and Treatment Strategies
por: MacDonald, Brittany, et al.
Publicado: (2022)

Angiotensin in Critical Care
por: Hall, Anna, et al.
Publicado: (2018)

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
por: Wieruszewski, Patrick M., et al.
Publicado: (2023)

Low dose sacubitril/valsartan is effective and safe in hemodialysis patient with decompensated heart failure and hypotension: A case report
por: Feng, Yunlin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iqkvn5joor27r4s7udqgu1f9gf